Cannae Q3 net earns $55.3M ($0.69) vs loss; buys back 1.7M shares; monetizes AmeriLife and CorroHealth

Cannae Holdings, Inc.

2022-Q3 EPS reported -$5.49 revenue$222,700,000

Q3 net earnings $55.3M ($0.69 diluted EPS) vs net loss $121.0M ($(1.36)) in Q3 2021.
Operating revenue fell 11.5% to $164.5M; operating loss improved to $(21.3)M from $(24.8)M.
Repurchased 1.7M shares for ~$36M in Q3; YTD 8.9M shares for $185M (10% of shares outstanding since Dec 2021).
Sold 46% of AmeriLife stake for $148M net cash in Aug; to sell another 29% in Q4 for ~$95M; total $243M.
Finalized sale of CorroHealth for ~$79M cash; committed ~$126M as 50.1% LP in AFC Bournemouth acquisition.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

Cannae Holdings, Inc. reported financial results for third quarter ended September 30, 2022.

Period: third quarter ended September 30, 2022
Result: reported results

Exact text from the filing

On November 9, 2022 , Cannae Holdings, Inc. (the "Company") issued a press release announcing its financial results for the third quarter of 2022.

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

Cannae Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001704720-22-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.